1. Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer;Lee;Sci Rep,2018
2. CA 19-9 response: a surrogate to predict survival in patients with metastatic pancreatic adenocarcinoma;Diaz;Am J Clin Oncol,2019
3. Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic diseases;Yue;Proteomics,2011
4. Monoclonal antibody against sialylated Lewis (a) antigen;Herrero-Zabaleta;Bull Cancer,1987
5. Exploiting the relevance of CA 19-9 in pancreatic cancer;Salleh;J Cancer Metastasis Treat,2020